Location History:
- Manitoba, CA (2008 - 2014)
- Winnipeg, CA (2011 - 2017)
Company Filing History:
3 out of 2,945 
3 out of 8 
2 out of 7 Years Active: 2008-2017
Title: **Joycelyn Entwistle: A Pioneer in Antibody Innovations**
Introduction
Joycelyn Entwistle, based in Winnipeg, Canada, has made significant strides in the field of biomedical innovation. With a total of nine patents to her name, she has contributed extensively to advancements in antibody therapies and diagnostic methods. Her work continues to influence research and application in the medical field.
Latest Patents
Among Joycelyn's latest inventions are innovative compositions of antibodies targeting the epithelial cell adhesion molecule (EpCAM). One notable patent focuses on anti-EPCAM antibodies and methods of use, detailing compositions that potentially lack T-cell epitopes, resulting in reduced immune responses. These antibodies may exist as fragments or in multiple forms, enabling diverse therapeutic applications.
Another significant patent relates to tumor-specific antibodies, providing both the amino acid and nucleic acid sequences of crucial regions. This innovation also includes methods for employing these antibodies in diagnostics and therapeutics, emphasizing their use in immunoconjugates with various effector molecules.
Career Highlights
Joycelyn has built her career by collaborating with prominent companies such as Merck Patent GmbH and Viventia Bio Inc. Her roles in these organizations have been pivotal in the development of her patent portfolio, allowing her to explore and refine her innovative ideas effectively.
Collaborations
Throughout her career, Joycelyn has worked alongside distinguished colleagues like Jeannick Cizeau and Nicholas Ronald Glover. These partnerships have enhanced her research efforts, fostering a collaborative environment that promotes groundbreaking advancements in their field.
Conclusion
Joycelyn Entwistle represents a robust example of innovation in the life sciences sector. Her contributions through her patents not only highlight her talent as an inventor but also signify the potential for future advancements in antibody therapies and diagnostics. Her ongoing work continues to inspire and pave the way for breakthroughs in medical research.